Fempharma's portfolio

We are proud to announce that our U.S. patent US 12,268,712B2 has officially been granted. This milestone recognizes our innovation and dedication in the field of women’s health and specifically postnatal regeneration. 

Around three quarters of women develop vaginal yeast infections at least once in their lifetime, and approximately 140 million women globally suffer from recurrent infections. Recurrent yeast infections can have an enormous impact of quality of life. Existing anti-fungal treatments are not always effective and resistance against these treatments is developing. Vaginal yeast infection is caused by a yeast called Candida. 

In a paper, published in Science Translational Medicine, we have shown that JUVIAGEL could be effective against recurrent yeast infections. 

Fempharma's website

INCOXIL is a patented dietary supplement for stronger pelvic floor muscles and less urinary incontinence.

MOMAID is a patented postpartum dietary supplement to support healthy recovery after delivery.

New approach for the treatment of vaginal dryness and vulvovaginal candidiasis